These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1611716)

  • 1. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis.
    Mathieson PW; Lockwood CM; Oliveira DB
    Clin Immunol Immunopathol; 1992 May; 63(2):135-41. PubMed ID: 1611716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.
    Griffith ME; Coulthart A; Pusey CD
    Clin Exp Immunol; 1996 Feb; 103(2):253-8. PubMed ID: 8565308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-neutrophil cytoplasmic antibody--enzyme immunosorbent assay].
    Arimura Y; Marumo T; Fujii A; Nakabayashi K; Nagasawa T
    Rinsho Byori; 2001 Jun; 49(6):571-4. PubMed ID: 11452543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis.
    Clayton AR; Savage CO
    Clin Exp Immunol; 2003 Apr; 132(1):174-9. PubMed ID: 12653854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis.
    Frampton G; Jayne DR; Perry GJ; Lockwood CM; Cameron JS
    Clin Exp Immunol; 1990 Nov; 82(2):227-32. PubMed ID: 2242605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.
    Rasmussen N; Petersen J
    J Autoimmun; 1993 Apr; 6(2):227-36. PubMed ID: 8499060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of anti-neutrophil cytoplasm autoantibodies in systemic vasculitides.
    Lai KN; Jayne DR; Brownlee A; Lockwood CM
    Clin Exp Immunol; 1990 Nov; 82(2):233-7. PubMed ID: 1978701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis.
    Short AK; Lockwood CM; Bollen A; Moguilevsky N
    Clin Exp Immunol; 1995 Oct; 102(1):106-11. PubMed ID: 7554375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
    DeHeer DH; Edgington TS
    J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-neutrophil cytoplasmic autoantibody (ANCA) in systemic vasculitic syndrome].
    Arimura Y; Nagasawa T
    Rinsho Byori; 1993 Aug; 41(8):866-75. PubMed ID: 8371502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.
    King WJ; Brooks CJ; Holder R; Hughes P; Adu D; Savage CO
    Clin Exp Immunol; 1998 Jun; 112(3):539-46. PubMed ID: 9649227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays.
    Esnault VL; Short AK; Audrain MA; Jones SJ; Martin SJ; Skehel JM; Lockwood CM
    Kidney Int; 1994 Jul; 46(1):153-60. PubMed ID: 7933832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of anti-neutrophil cytoplasmic antibodies with proteinase 3 specificity by immunoblotting].
    Chevailler A; Taouil K; Carrère F; Renier G; Hurez D
    Pathol Biol (Paris); 1994 Jun; 42(6):575-80. PubMed ID: 7854857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
    Falk RJ; Terrell RS; Charles LA; Jennette JC
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4115-9. PubMed ID: 2161532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.
    Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD
    Arthritis Rheum; 2010 May; 62(5):1539-48. PubMed ID: 20155828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.